NL8803196A - Nieuwe op 17alfa gesubstitueerde 17beta-hydroxy-19-norsteroiden, werkwijze voor de bereiding daarvan, hun toepassing als geneesmiddelen en farmaceutische preparaten die ze bevatten. - Google Patents

Nieuwe op 17alfa gesubstitueerde 17beta-hydroxy-19-norsteroiden, werkwijze voor de bereiding daarvan, hun toepassing als geneesmiddelen en farmaceutische preparaten die ze bevatten. Download PDF

Info

Publication number
NL8803196A
NL8803196A NL8803196A NL8803196A NL8803196A NL 8803196 A NL8803196 A NL 8803196A NL 8803196 A NL8803196 A NL 8803196A NL 8803196 A NL8803196 A NL 8803196A NL 8803196 A NL8803196 A NL 8803196A
Authority
NL
Netherlands
Prior art keywords
formula
hydroxy
compound
compounds
dimethylamino
Prior art date
Application number
NL8803196A
Other languages
English (en)
Dutch (nl)
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8718376A external-priority patent/FR2625505B2/fr
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of NL8803196A publication Critical patent/NL8803196A/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL8803196A 1987-12-30 1988-12-29 Nieuwe op 17alfa gesubstitueerde 17beta-hydroxy-19-norsteroiden, werkwijze voor de bereiding daarvan, hun toepassing als geneesmiddelen en farmaceutische preparaten die ze bevatten. NL8803196A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8718376 1987-12-30
FR8718376A FR2625505B2 (fr) 1981-01-09 1987-12-30 Nouveaux derives steroides substitues en 11beta leur procede de preparation et leur application comme medicaments et les compositions pharmaceutiques les renfermant

Publications (1)

Publication Number Publication Date
NL8803196A true NL8803196A (nl) 1989-07-17

Family

ID=9358447

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8803196A NL8803196A (nl) 1987-12-30 1988-12-29 Nieuwe op 17alfa gesubstitueerde 17beta-hydroxy-19-norsteroiden, werkwijze voor de bereiding daarvan, hun toepassing als geneesmiddelen en farmaceutische preparaten die ze bevatten.

Country Status (14)

Country Link
US (1) US5006518A (fr)
JP (1) JP2785023B2 (fr)
AT (1) AT396787B (fr)
BE (1) BE1004905A4 (fr)
CA (1) CA1303025C (fr)
CH (1) CH676852A5 (fr)
DE (1) DE3844408C2 (fr)
ES (1) ES2012197A6 (fr)
GB (1) GB2213484B (fr)
GR (1) GR880100868A (fr)
IT (1) IT1235358B (fr)
LU (1) LU87417A1 (fr)
NL (1) NL8803196A (fr)
SE (1) SE503267C2 (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2654337B1 (fr) * 1989-11-15 1994-08-05 Roussel Uclaf Nouvelles microspheres injectables biodegradables procede de preparation et suspensions injectables les renfermant.
DE4042004A1 (de) * 1990-12-22 1992-06-25 Schering Ag 14(beta)-h-, 14- u. 15-en-11(beta)-aryl-4-estrene
EP0496520A1 (fr) * 1991-01-22 1992-07-29 Merck & Co. Inc. Agents actifs sur les os
US6407082B1 (en) * 1996-09-13 2002-06-18 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a vitamin D compound
JP3862295B2 (ja) * 1993-09-30 2006-12-27 独立行政法人理化学研究所 抗肥満剤
US5780220A (en) * 1994-05-19 1998-07-14 Trustees Of The University Of Pennsylvania Methods and compositions for inhibiting HIV replication
US5639598A (en) * 1994-05-19 1997-06-17 The Trustees Of The University Of Pennsylvania Method and kit for identification of antiviral agents capable of abrogating HIV Vpr-Rip-1 binding interactions
EP0683172B1 (fr) * 1994-05-19 1997-08-13 Akzo Nobel N.V. Dérivés 11,21-bisphényle-19-nor-pregnanes
US6511970B1 (en) 1996-09-13 2003-01-28 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
US6765002B2 (en) 2000-03-21 2004-07-20 Gustavo Rodriguez Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium
US6034074A (en) 1996-09-13 2000-03-07 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a Vitamin D compound
US6028064A (en) * 1996-09-13 2000-02-22 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of progestin products
DE19706061A1 (de) * 1997-02-07 1998-08-13 Schering Ag Antigestagen wirksame Steroide mit fluorierter 17alpha-Alkylkette
US20010044431A1 (en) * 2000-03-21 2001-11-22 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
JP2001301596A (ja) 2000-04-19 2001-10-31 Sumitomo Denko Brake Systems Kk 車両用液圧ブレーキシステムの制御方法
EP2057182A2 (fr) * 2007-05-01 2009-05-13 Sicor, Inc. Procédé de préparation de la drospirénone et de produits intermédiaires de celle-ci
US11103514B2 (en) 2010-05-26 2021-08-31 Corcept Therapeutics, Inc. Treatment of muscular dystrophy
EP3265127B1 (fr) 2015-03-02 2024-02-21 Corcept Therapeutics, Inc. Mifepristone et octreotide pour le traitement du syndrome de cushing chez un patient ayant une tumeur neuroendocrine pancréatique sécrétant l'hormone adrénocorticotrope (acth)
ES2906778T3 (es) 2015-03-30 2022-04-20 Corcept Therapeutics Inc Uso de antagonistas del receptor de glucocorticoides en combinación con glucocorticoides para tratar la insuficiencia suprarrenal
JP6768789B2 (ja) 2015-08-13 2020-10-14 コーセプト セラピューティクス， インコーポレイテッド Ａｃｔｈ依存性クッシング症候群を鑑別診断する方法
JP6995757B2 (ja) 2015-12-23 2022-01-17 オリック ファーマシューティカルズ，インク． グルココルチコイド受容体の阻害剤
US11124537B2 (en) 2015-12-23 2021-09-21 Oric Pharmaceuticals, Inc. Inhibitors of glucocorticoid receptor
US11110103B2 (en) 2015-12-23 2021-09-07 Oric Pharmaceuticals, Inc. Inhibitors of glucocorticoid receptor
EP3405101B1 (fr) 2016-01-19 2020-12-23 Corcept Therapeutics, Inc. Diagnostic différentiel du syndrome de cushing ectopique
PT3523315T (pt) 2016-10-07 2021-04-29 Oric Pharmaceuticals Inc Inibidor de recetor de glucocorticoide
EP3641780A4 (fr) 2017-06-20 2021-02-24 Corcept Therapeutics, Inc. Méthodes de traitement des tumeurs neuro-épithéliales à l'aide de modulateurs sélectifs du récepteur de glucocorticoïdes
EP4263807A2 (fr) 2020-12-18 2023-10-25 Instil Bio (Uk) Limited Traitement de lymphocytes infiltrant les tumeurs

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2377418A1 (fr) * 1977-01-13 1978-08-11 Roussel Uclaf Nouveaux derives steroides 4,9-dieniques 11b-substitues, leur procede de preparation et leur application comme medicaments
ZA8231B (en) * 1981-01-09 1982-11-24 Roussel Uclaf New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained
FR2528434B1 (fr) * 1982-06-11 1985-07-19 Roussel Uclaf Nouveaux 19-nor steroides substitues en 11b et eventuellement en 2, leur procede de preparation et leur application comme medicament
EP0110434B1 (fr) * 1981-01-09 1986-10-29 Roussel-Uclaf Nouveaux produits intermédiaires stéroides substitués en 11-beta et procédé de préparation de ces produits
EP0116974B1 (fr) * 1983-02-18 1986-10-29 Schering Aktiengesellschaft 11-Bêta-aryl-estradiènes, procédé de préparation et compositions pharmaceutiques les contenant
FR2549067B1 (fr) * 1983-06-14 1985-12-27 Roussel Uclaf Derives estradieniques radioactifs marques au tritium, leur procede de preparation et leur application pour l'etude et le dosage radio-immunologique de steroides dans les fluides biologiques
ES533260A0 (es) * 1983-06-15 1985-02-01 Schering Ag Procedimiento para la preparacion de 13a-alquilgonanos
US4780461A (en) * 1983-06-15 1988-10-25 Schering Aktiengesellschaft 13α-alkyl-gonanes, their production, and pharmaceutical preparations containing same
DE3347126A1 (de) * 1983-12-22 1985-07-11 Schering AG, 1000 Berlin und 4709 Bergkamen 11ss-aryl-estradiene, deren herstellung und diese enthaltende pharmazeutische praeparate
FR2566779B2 (fr) * 1984-06-29 1987-03-06 Roussel Uclaf Nouveaux derives steroides substitues en 11b, leur procede de preparation et leur application comme medicaments
DE3506785A1 (de) * 1985-02-22 1986-08-28 Schering AG, Berlin und Bergkamen, 1000 Berlin 11ss-n,n-dimethylaminophenyl-estradiene, deren herstellung und diese enthaltende pharmazeutische praeparate
DE3619413C2 (de) * 1986-06-10 2000-04-06 Schering Ag 9alpha, 10alpha-Methylen-Estrene, deren Herstellung und diese enthaltende pharmazeutische Präparate
DE3625315A1 (de) * 1986-07-25 1988-01-28 Schering Ag 11ss-(4-isopropenylphenyl)-estra-4,9-diene, deren herstellung und diese enthaltende pharmazeutische praeparate
US4774236A (en) * 1986-09-17 1988-09-27 Research Triangle Institute 17α-(substituted-methyl)-17β-hydroxy/esterified hydroxy steroids and pharmaceutical compositions containing them
IE60780B1 (en) * 1987-01-23 1994-08-10 Akzo Nv New 11-aryl steroid derivatives

Also Published As

Publication number Publication date
GB2213484A (en) 1989-08-16
SE8804692D0 (sv) 1988-12-29
GB2213484B (en) 1991-10-09
SE8804692L (sv) 1989-07-01
ATA318788A (de) 1993-04-15
US5006518A (en) 1991-04-09
LU87417A1 (fr) 1989-06-14
JP2785023B2 (ja) 1998-08-13
GR880100868A (el) 1994-03-31
DE3844408A1 (de) 1989-07-13
JPH01213296A (ja) 1989-08-28
IT1235358B (it) 1992-06-30
ES2012197A6 (es) 1990-03-01
SE503267C2 (sv) 1996-04-29
BE1004905A4 (fr) 1993-02-23
DE3844408C2 (de) 2001-07-26
CH676852A5 (fr) 1991-03-15
IT8848730A0 (it) 1988-12-29
CA1303025C (fr) 1992-06-09
GB8830380D0 (en) 1989-03-01
AT396787B (de) 1993-11-25

Similar Documents

Publication Publication Date Title
NL8803196A (nl) Nieuwe op 17alfa gesubstitueerde 17beta-hydroxy-19-norsteroiden, werkwijze voor de bereiding daarvan, hun toepassing als geneesmiddelen en farmaceutische preparaten die ze bevatten.
DK175760B1 (da) 11beta-substituerede progesteronanaloger
KR930005993B1 (ko) 위치 10에 치환된 스테로이드의 제조방법
US3239417A (en) Methods and compositions for inhibiting sterol biosynthesis
AU699701B2 (en) Estra-1,3,5(10)-triene derivatives, processes for their preparation and pharmaceutical compositions containing these compounds
DE19651000A1 (de) Oxyiminopregnancarbolactone
CZ278094A3 (en) Competitive progesteron antagonist and use thereo competitive progesteron antagonist and use thereof f
DE4332284A1 (de) Neue 11-Benzaldoxim-17beta-methoxy-17alpha-methoxymethyl-estradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DK145610B (da) 3-oximer af 17alfa-ethynyl-19-nortestosteronestere til anvendelse til undertrykkelse af fertilitet
CA2384184C (fr) 17.beta.-acyl-17.alpha.-propynyl-11.beta.-(cyclic amino) aryl-steroides et leurs derives presentant des proprietes hormonales antagonistes
JP4392066B2 (ja) 避妊活性及び抗骨粗鬆症活性を有するステロイド化合物
JP3026997B2 (ja) １９―ノルステロイドから導かれる基が芳香族核上に置換している新規なω―フェニルアミノアルカン酸及びそれらの塩類、これらの製造法、この製造法の新規な中間体、これらの薬剤としての使用並びにこれらを含有する組成物
JP4002438B2 (ja) ステロイド類、それらの調製、それらの薬学的組成物およびこの化合物の使用
JPS6355488B2 (fr)
WO1999045886A2 (fr) Nouveau kit de contraception
JP2001507010A (ja) １１位が置換されたステロイド、それらの製造方法、それらの薬剤としての用途及びそれらを含有する製薬組成物
DE60026608T2 (de) 3-methylen steroid derivate zur behandlung von autoimmunerkrankungen
US5866559A (en) 17α-cyanomethylestra-4,9-dien derivatives and pharmaceutical compositions containing same
DE1951990C3 (de) 3-Cyciopentyloxy-13-äthyl-17alphaäthinylgona-3,5-dien-17beta-ol und dessen Acylderivate
JPS6249280B2 (fr)
DE3644358A1 (de) 10(beta)-alkynyl-4,9(11)-oestradien-derivate, verfahren zu deren herstellung und arzneimittel, welche diese enthalten
DE1793422C3 (de) 4,6-Dichlor-4,6-östradiene, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel, sowie rac-u.nat. 6-Chlor- lTbeta-acetoxy-ie-methyl-17 a-äthinyl-4,6-östradien-3-on als Ausgangsverbindungen
FR2625505A2 (fr) Nouveaux derives steroides substitues en 11beta leur procede de preparation et leur application comme medicaments et les compositions pharmaceutiques les renfermant
WO2007062876A1 (fr) Promedicaments de substances er-beta-selectives, procedes de realisation associes et compositions pharmaceutiques contenant ces composes
CA2631364A1 (fr) Derives 11.beta.-benzaldoxime de d-homooestra-4,9-dien-3-ones

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
CNR Transfer of rights (patent application after its laying open for public inspection)

Free format text: HOECHST ROUSSEL VET S.A.

BV The patent application has lapsed